baber/WOPTO huggingface dataset:
Patent PT-2225852-E (PT)
Title: A system for managing and supervising networked equipment according to the snmp protocol, based on switching between snmp managers
Inventor: BRUNO VITTORIO
IPC: H04L12/24
Filed: 2008-12-22
Abstract: There is described a system for managing and supervising networked equipment according to an SNMP protocol, comprising: - plurality of management agents, each of which is associated with a corresponding network equipment item (M1-M5) belonging to a community and arranged to carry out management decisions in the context of the associated equipment (M1-M5); - plurality of MIB databases, each of which is associated with a respective managed equipment item (M1-M5) and includes a set of state data for the equipment item, which MIB databases are accessible to the agent operating on the monitored equipment item; and - a plurality of manager modules (MAN1-MAN5) adapted to take management decisions under the control of an operator, each of which is arranged to access a MIB database of a respective managed equipment item (M1-M5) in order to send requests and/or to receive notifications, characterized in that it includes a module (SCSM) for controlling the switching between managers (MAN1-MAN5) of equipment items which are linked in a logical community (MGL) in order to manage a workload distributed over several equipment items (M1-M5), in which the MIB databases of every management agent for the equipment items (M1-M5) are aligned in content, which module is arranged to define a manager-agent management connection for managing all the equipment items (M1-M5) of the logical community (MGL), and in that the switching control module (SCSM) is adapted to receive commands from an operator and is arranged to dynamically select one of the plurality of managers (MAN1- MAN5) available depending on the state of the monitored equipment (M1-M5) and on the associated agent and based on a pre-established order of priority among managers (MAN1- MAN5).
Patent PT-717989-E (PT)
Inventor: VALDIVIA FRANCISCO JAVIER GALA
IPC: A61K9/51
Filed: 1994-09-30
Abstract: The process comprises: (1) preparing a fine dispersion of droplets or particles which contain or are formed of a chemical or biologically active substance in a phase comprised of a solvent and a non solvent of the polymer forming the coating and optionally a surfactant or suspensor agent; (2) preparing a phase which contains the coat-forming polymer dissolved in a miscible solvent in any proportion with the prior dispersion; (3) mixing both phases continuously while maintaining constant the relationship between the phases and the mixture volume and simultaneously spraying the resultant mixture in an evaporation system with temperature and vacuum conditions which provide for the instantaneous evaporation of the solvent from the polymer, causing the deposition of the polymer around the particles or droplets. Application to pharmacy, medecine, cosmetics, veterinary, chemical industry, agriculture, etc. <IMAGE>
Patent PT-693355-E (PT)
Inventor: HAWRYLKO ROMAN BOHDAN
IPC: B29C48/41
Filed: 1995-07-18
Abstract: A process for the extrusion of rigid PVC profile other than pipe is disclosed in a twin conical screw extruder, equipped with high shear screws. The process comprises extruding a compound specially adapted for the process, the compound comprising a polyvinyl chloride resin with an average particle size of from 130 to about 200 microns, a lubricant system containing no more than about 3.5 parts of one or more lubricants, an organo metal salt, from 0 to less than 0.75 parts of a polymeric processing aid, at least one filler/pigment, and a stabilizer for PVC. The process achieves extrudate surfaces characterized by a smooth, dull finish. The process advantageously operates at high extrusion output rates under the conditions specified.
Patent PT-694562-E (PT)
Inventor: TSAY GRACE C
IPC: A61K38/55
Filed: 1995-07-19
Abstract: Human  alpha 1-antichymotrypsin (ACT) can be purified from solutions containing human  alpha 1-proteinase inhibitor (PI) and antithrombin III (AT-III) using chromatography adsorption steps at carefully controlled pH and conductivity. The separated ACT retains in vitro inhibitory capacity and has potential therapeutic use.
Patent PT-800479-E (PT)
Inventor: AUCLAIR JEAN-MICHEL
IPC: B65D85/20
Filed: 1996-01-11
Abstract: A carton for packaging a plurality of articles, which carton comprises a first panel (118,218,330) having a corner; a second panel (114,214,316) neighbouring said first panel, adjacent edges of said first and second panels being disposed to converge on said corner; and a gusset (138,338) extending between said adjacent edges and foldably connected to said first and second panels along said adjacent edges, said gusset comprising a pair of gusset panels (158,160,358,360) interconnected along a fold line, characterised in that said first panel has an end panel (128,228,328) foldably connected thereto, and one (158,358) of said gusset panels comprises means (159,359) for operably abutting said end panel to help retain said second panel in a formed position upon formation of said carton.
Patent PT-873382-E (PT)
Inventor: SHARPE JOHN ERNEST ELSOM
IPC: F27D3/00
Filed: 1996-10-25
Abstract: PCT No. PCT/GB96/02169 Sec. 371 Date Apr. 27, 1998 Sec. 102(e) Date Apr. 27, 1998 PCT Filed Oct. 25, 1996 PCT Pub. No. WO97/15641 PCT Pub. Date May 1, 1997A process for the production of heat energy from solid carbonaceous fuels is disclosed which comprises subjecting the carbonaceous fuel to substantially anaerobic pyrolysis in at least one first zone and thereafter transferring the char resulting from the pyrolysis to a second zone which is segregated from the first zone or zones. The char is subjected to gasification in the second zone by introduction of primary combustion air, optionally with steam and/or recycled exhaust gas. The off gases from the second zone and the pyrolysis gases from the first zone or zones are thereafter subjected to secondary combustion and the first zone or zones is heated by heat derived from the secondary combustion. Ash is removed from the bottom of the second zone.
Patent PT-892794-E (PT)
Inventor: SCHNEIDER JOHANNES
IPC: C07D401/04
Filed: 1997-03-22
Abstract: Thalidomide prodrugs of the formula I:in which R is -CHR1-NHR2 or -(CH2)nCOOH; R1 is H or C1-4 alkyl; R2 is H, C1-3 alkyl, C(O)-CH2-NHR3 or an amino-protective group, R3 is H or an amino-protective group, and n is an integer from 2 to 4, in the form of their free bases or of salts with physiologically acceptable acids, as well as a process for preparation of such prodrugs and the use of such prodrugs as an active drug substance.
Patent PT-1181204-E (PT)
Inventor: FOX KENNETH S
IPC: B65D30/06
Filed: 1999-10-14
Abstract: A produce bag having at least one side wall of a cross-laminated synthetic resin fabric mesh material is provided with increased strength and reliability for use with automatic bag filling equipment. The other wall is of a synthetic resin film, or of the same type of mesh material, if desired. A reinforcing strip of synthetic resin film is formed along an upper portion of a mesh material wall of the bag where spaced holes for wicket pin attachment are formed. The bag provides greater strength, uniformity, and reliability in automatic produce packing machine operations.
Patent PT-1140158-E (PT)
Title: Multi-component vaccine comprising at least two antigens from haemophilus influenzae
Inventor: YANG YAN-PING
IPC: C07K14/285
Filed: 1999-12-15
Abstract: A multi-component immunogenic composition confers protection on an immunized host against infection caused by Haemophilus influenzae. Such composition comprises at least two different antigens of Haemophilus influenzae, one of which is an adhesin. High molecular weight (HMW) proteins of non-typeable Haemophilus influenzae enhance the immune response in a host to a non-proteolytic analog of Hin47 protein in such immunogenic compositions with one component not impairing the immunogenicity of the other. The Haemophilus vaccine may be combined with DTP component vaccines to provide a multi-valent component vaccine without impairment of the immunogenic properties of the other antigens.
Patent PT-1144009-E (PT)
Inventor: SISTA HEMA S
IPC: A61K47/14
Filed: 1999-12-02
Abstract: Stable pharmaceutical compositions comprising recombinant adeno-associated virus (AAV) virions are described. The compositions provide protection against loss of recombinant AAV vector genomes and transduceability under conditions such as exposure to cycles of freezing and thawing and storage in glass or polypropylene vials. The compositions comprise recombinant AAV virions in combination with one or more dihydric or polyhydric alcohols, and, optionally, a detergent, such as a sorbitan ester. Also described are methods of using the compositions.
Patent PT-1140166-E (PT)
Title: Adjuvant containing n-formyl methionyl peptides for vaccines
Inventor: ALEXANDER JEANNINE
IPC: A61P37/04
Filed: 1999-12-17
Abstract: The present invention relates to immunological adjuvants comprised of the N-formyl methionyl peptide fMLP. fMLP, when used as an adjuvant in accordance with the present invention, provides for an immune response to suboptimal doses of recombinant antigens.
Patent SG-1195-G (SG)
Title: Ornamental chain
Inventor: BUNZ GEORG
IPC: A44C11/00
Filed: 1995-01-04
Abstract: An ornamental chain consists of a core made of at least two parallel or twisted strings (11, 12, 13) and at least one metal wire (10) passing around said core, essentially punctiform contact surfaces (K) being formed between each string (11, 12, 13) and the metal wire (10). As a result, a very "free" fastening of the peripheral metal wire (10) is achieved by the core, and the bending behaviour of the peripheral metal wire (10) is very even due to the multi-point fastening by the continuous strings (11, 12, 13). The strings are preferably formed from metal or a metal alloy so that a high mechanical stability of the core can also be achieved.
Patent SG-58193-G (SG)
Title: Matching a multi-working mode monitor with a personal computer
IPC: G09G1/04
Filed: 1993-05-04
Abstract: PCT No. PCT/EP88/00581 Sec. 371 Date Mar. 1, 1989 Sec. 102(e) Date Mar. 1, 1989 PCT Filed Jul. 1, 1988 PCT Pub. No. WO89/00325 PCT Pub. Date Jan. 12, 1989.An adapter for a multiple operating mode monitor automatically controls the horizontal and vertical deflection circuits of the monitor cathode ray tube depending upon the characteristics of the video source to which the monitor is connected. The adapter has a digital memory for storing sets of monitor operating parameters for each of a plurality of predetermined operating modes at selectively addressable locations. A processor evaluates horizontal and vertical synchronizing signals from a video source to which the monitor is connected to identify one of the plurality of predetermined operating modes corresponding to the synchronizing signals. The operating mode may be evaluated and identified by measuring the period of the horizontal and vertical synchronizing signals form the video source. The memory location corresponding to the identified mode of operation is selectively addressed, the selected set of operating parameters, which may be in parallel format, being available as an output to a plurality of dynamic digital to analog converters. The digital to analog converters, which may be synchronized with the vertical frequency, provide analog control signals for the horizontal and vertical deflection circuits. The horizontal and vertical deflection circuits are adjusted responsive to the analog control signals to correspond to the selected set of operating parameters. The operating parameters may include horizontal and vertical frequency, horizontal and vertical amplitude, horizontal and vertical deflection phase position, brightness and contrast.
Patent IE-890163-L (IE)
Title: Low energy fuse and method of manufacture
IPC: C08J7/06
Filed: 1989-01-19
Abstract: A low energy fuse is extruded as a single ply primary tube 1 from a plastic resin blend with particulate energetic material 2 being internally distributed in a manner known per se, said resin blend comprising a major amount of an orientable polymer, for example, linear low density polyethylene to provide structural integrity and a minor amount of a modifier to impart enhanced particle retentive properties to the tube and preferably also containing a polymer or copolymer to impart melt strength and aid in tube extrusion.
Patent IE-44364-L (IE)
Title: Thienothienylcarbonylphenylalkanoic acid derivatives
IPC: C07D333/24
Filed: 1977-01-28
Abstract: Compounds of the formula: <IMAGE> wherein R represents hydrogen or an alkyl radical, R1 represents a hydroxy, amino or alkoxy radical or an alkylamino or dialkylamino group, the various alkyl radicals and the alkoxy radical being optionally substituted by a dialkylamino group, the alkyl radicals of the said dialkylamino groups optionally being linked together to form a heterocyclyl radical with 5 or 6 atoms in the ring, and A represents the thieno[2,3-b]thien-2-yl or thieno[3,2-b]thien-2-yl radical, the A-CO- grouping being attached to the 3- or 4-position of the phenyl ring, have been found to possess useful pharmacological properties and are particularly active as analgesics, antipyretics, agents for inhibiting platelet aggregation and as anti-inflammatory agents.
[US4124596A]
Patent IE-850565-L (IE)
Title: Pre-s gene coded peptide hepatitis b immunogens, vaccines,¹dasgnostics, and synthetic lipid vesicle carriers
IPC: A61K47/48
Filed: 1985-03-06
Abstract: A hepatitis B vaccine containing a peptide with an amino acid chain of at least six consecutive amino acids within the pre-S gene coded region of the envelope of hepatitis B virus. The vaccine being free of an amino acid sequence corresponding to the naturally occuring evelope proteins of hepatitis B virus and a physiologically acceptable diluent. The peptide being free or linked to a carrier. The carrier being a conventional carrier or a novel carrier including a lipid vesicle stabilized by cross-linking and having covalently bonded active sites on the outer surface thereon. Such novel carrier being useful not only to link the novel peptide containing an amino acid chain with amino acids within the pre-S gene coded region of the surface antigen of hepatitis B virus, but can also be used to bind synthetic peptide analogues of other viral proteins, as well as bacterial, allergen and parasitic proteins of man and animals. The peptides of the invention can be utilized in diagnostics for the detection of antigens and antibodies.
Patent IE-860665-L (IE)
Title: Ceramic cutting tool
IPC: C04B35/80
Filed: 1986-03-13
Abstract: Tool comprises ceramic matrix reinforced by 2-40 vol.% ceramic whiskers; specific compsns. are alumina matrices contg. 2-40 or about 25 vol.% SiC whisker. Pref. compsns. are 20-35 and 2-12 vol.% whiskers which are pref. Al2 O3, AlN, BeO, B4C, graphite or Si3N4 or esp. SiC or mixts. thereof. Al2O3 matrix can pref. include s mall amts. of ZrO2, Y2O3, HfO2, MgO, Si3N4 or TiC. Matrix can pref. be Si3N4. -
Cutting tools are disclosed which are comprised of composite bodies comprising a ceramic matrix reinforced by ceramic whiskers. The ceramic matrix may be alumina or silicon nitride, and may contain toughening components. The whiskers are preferably silicon carbide, but may be other known ceramic whiskers. Whisker content in the composite is 2-40%, with higher contents generally used for tools when the expected service involves interrupted cutting and lower contents generally used for continuous cutting tools.
[EP0194811A2]
Patent IE-33835-L (IE)
Title: Peptides
IPC: C07K5/103
Filed: 1969-10-10
Abstract: 1287125 Calcitonin derivatives CIBAGEIGY AG 13 Oct 1969 [15 Oct 1968 20 Nov 1968] 50087/69 Heading C2C Peptides (I) in which at least one and at the most 16 of the amino acids in positions 2, 8, 10, 11, 12, 13, 14, 16, 18, 21, 23, 24, 25, 26, 27, 29, 30 and 31 are replaced by other natural α-amino acids or their homologues their dimers and derivatives (especially their N-acylated and desamino<SP>1</SP>- peptides) of the mono- or di-meric peptides as well as their acid addition salts and complexes are prepared (1) by removing the blocking groups from a compound (I) in which any free amino or carboxylic acid group is blocked or (2) by oxidizing the linear peptide corresponding to (I) and wherein the mercapto groups may be tritylated or (3) by condensing a compound (III) or (IV) or where Y is Gly or Ser, A is 1-21 of the amino acid residues following upon Cys<SP>7</SP> and R is H or an acylated amino group, with the remaining amidated C-terminal sequence of the peptide in which any side chain amino group is protected. The following starting materials are prepared: Z- and H-Ala-Pro-OtBu, Z- and H-Qly-Ala- ProOtBu, Z - Val - Gly - Ala - ProOtBu and -OH and -NH 2 , H-Val- Gly - Ala - Pro - NH 2 , Z. and H - Ile - Gly OMe, Z- and H -Ala-Ile- Gly OMe, BOC - Thr - Ala - Ile-Gly-OMe and -NHNH 2 , BOC and H - Thr - Ala - He - Gly- Val - Gly - Ala - ProNH 2 , Z- and H - Pro - Gln- NHNHBOC, Z- and H - Phe - Pro - Gln- NHNHBOC, Z- and H - Thr - Phe - Pro - Gln- NHNHBOC, Z - His - Thr - Phe - Pro - Gln- NHNHBOC and -NHNH 2 , Z - His - Thr- Phe - Pro - Gln - Thr - Ala - lie - Gly - Val - Gly- Ala - ProNH 2 Z - Lys (BOC) - Phe - OBzl, H- lys(BOC)PheOH, Z- and H - Asn - Lys(BOC}- Phe - OH, Z - Asp(OtBu) - Phe - OMe and -NHNH 2 , Z- and H - Asp(OtBu) - Phe - Asn- Lys(BOC} - Phe - OH, BOC- and H - Tyr - Thr- ONB, Z - Thr - Tyr - Thr - ONB and -NHNH 2 , Z - Thr - Tyr - Thr - Gln - NHNHBOC and - NHNH Z , Z- and H - His - Thr - Phe - Pro- Gln . Thr - Ala - Ile - Gly - Val - Gly - Ala - Pro- NH 2 , Z- and. H - Thr - Tyr - Thr - Gln -Asp- (OtBu) - Phe - Asn - Lys(BOC) - Phe - His - Thr- Phe . Pro - Gln - Thr - Ala - lie - Gly - Val - Gly- Ala - Pro - NH 2 , BOC - Ser - Thr - OBzl, HSer - Thr - OBzl, BOC- and H - Leu - Ser - Thr OBzl, BOC- and H - Asn - Leu - Ser - Thr- OBzl, BOC - Gly - Asn - Leu - Ser - Thr - OBzl and OH BOC and H-Gly-Asn-Leu-Ser-Thr- Thr(tBu) - Phe - Pro - Gln - Thr(tBu) - Ala - Ile- Gly - Val - Gly - Ala - Pro - NH 2 . Pharmaceutical compositions useful as hypocalcaemic agents comprise compounds (I) and a carrier and are in forms suitable for oral and parenteral administration.
[GB1287125A]
Patent IE-852013-L (IE)
Title: Pressure saturation of substrate
IPC: B05D1/18
Filed: 1985-08-15
Abstract: A pressure saturator for impregnating a substrate with a saturant is disclosed, having a block member with an arcuate, sloping upper surface that is graduated from a relatively deep portion to a relatively shallow portion. Rollers are disposed on each side of the block member for conveying the substrate into and out of the saturator, and a mandrel is disposed between the rollers for guiding the substrate through the saturator. The lower portion of the mandrel is spaced from the block member and extends into the recess formed by the arcuate surface to define a chamber therebetween. The chamber has an inlet and an outlet for admitting the substrate and the saturant, and converges in depth from the inlet region to the outlet region to pressurize the solution and force the saturant into the interstices of the substrate.
[US4588616A]
Patent IE-792028-L (IE)
Title: Pyrroloazetidinones
IPC: C07C205/42
Filed: 1979-10-23
Abstract: Disclosed are 1-, 6- and 2-substituted-1-carba-2-penem-3-carboxylic acids of the following structure:  <IMAGE>  wherein R1, R2, R3 and R4 are, inter alia, independently selected from the group consisting of hydrogen, alkyl, aryl, and aralkyl. Such compounds as well as their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.
Patent IE-782040-L (IE)
Title: Protective circuit for electrically heated blanket
IPC: H02H5/04
Filed: 1978-10-13
Abstract: THE INVENTION RELATES TO A PROTECTIVE CIRCUIT COMPRISING AN INTERIOR DRIVER AND A OUTER MAIN CONNECT WITH A FUSE AND A FIRST RECTIFIER HALF-WAVE. [FR2408932A1]
Patent IE-842189-L (IE)
Title: Rupture disc
IPC: F16K17/16
Filed: 1984-08-27
Abstract: A rupture disc system comprises a rupture disc including a dome portion and a flange portion interconnected by a transition region and a mounting mechanism for mounting the rupture disc by the flange portion thereof in a pressure relieving vent. The rupture disc includes a thickness reducing groove at least partially circumferentially surrounding the dome portion and located in the transition region thereof. Preferably, the rupture disc is of the reverse buckling type and the groove does not completely surround the dome portion so as to define a tab or hinge within that part of the transition region which is ungrooved or not as deeply grooved as a remainder of the transition region. In addition, the slope or radius of curvature may be increased in the region of the tab. The rupture disc also includes an tion on the dome portion. The indentation is preferably greatest on the dome portion at a location spaced from the transition region and directly between the tab and a crown of the dome portion. In addition, the mounting mechanism includes a lower ring member having an arcuate projection which extends into the vent. Preferably, the arcuate projection is located so as to be relatively close to and so as to align with the tab such that the dome portion wraps about the projection when reverse buckling and rupture occurs. Methods are disclosed for producing the disc with the groove and the indentation.
[EP0137903A1]
Patent IE-902235-L (IE)
Title: Pesticidal Composition
IPC: C07C269/06
Filed: 1990-06-20
Abstract: Ethyl 2-[4-(3-chlorophenoxy)phenoxy]ethylcarbamate is suitable controlling phytophagous cicadas in rice crops and fruit pests such as leaf rollers, citrus fruit pests such as scale insects, and vegetable and cotton pests such as white flies and noctuids.
Patent IE-792416-L (IE)
Title: Producing textile laminates
IPC: B32B25/10
Filed: 1979-12-13
Abstract: A process for forming a high viscosity coating composition from low viscosity polymeric colloidal dispersion by substantially effecting the thickening of the colloidal dispersion in a mixing head, and for producing from the mixing head a range of high viscosity coatings using the same low viscosity polymeric colloidal dispersion.
Patent IE-842571-L (IE)
Title: Making cushions
IPC: A47C31/11
Filed: 1984-10-08
Abstract: A novel process is disclosed for forming cushion articles with a cloth covering dyed and set as the cushion forms a male mold for the covering. The process entails placing unfinished cloth over a three-dimensional mold and dyeing and teating the cloth while on the mold so that the cloth will be colored and will retain the predetermined shape when removed from the mold. The cloth may be an undyed polyester product which is dyed by optionally first chemically treating the cloth to lower the fabric heat history characteristics and hence its ability to absorb dye and then by dipping the cloth and mold into a dye bath. The dye bath may be heated above the heat set threshold of the polyester fabric so that the dyeing step is performed at the same time as the step to effect the set or dimensional stability of the fabric.
[EP0145168A2]
Patent IE-892828-L (IE)
Title: Process for making shelf-stable (aseptic) orange-juice¹containing beverages
IPC: A23L27/12
Filed: 1989-09-01
Abstract: Process for making shelf-stable, orange-juice containing beverages, which approach the quality of freshly-squeezed orange juice, while using commercially available sources and equipment. The obtained products have a titratable orange oil content of less than 0.015%, and are further characterised by a relatively high ratio of desirable to less desirable specific flavour and aroma components.